GWM
UTHR icon

Gupta Wealth Management’s United Therapeutics UTHR Stock Holding History

Gupta Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$31K Buy
279
+176
+171% +$22.3K 0.01% 563
2015
Q4 		$16K Buy
+103
New +$15K ﹤0.01% 745

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Gupta Wealth Management's UTHR Position: Q1 2016 in Review

Gupta Wealth Management increased its United Therapeutics (UTHR) stake by 171% in Q1 2016, buying an estimated $22.3K and bringing the position to 279 shares worth $31K. The position accounts for 0.01% of the portfolio, ranked #563.

Gupta Wealth Management first reported a position in UTHR in Q4 2015 and has held it in 2 quarters since. 399 funds tracked by Wall St. Rank hold UTHR as of Q1 2016.

  • Gupta Wealth Management held 279 shares of United Therapeutics worth $31K as of Q1 2016.
  • Gupta Wealth Management bought 176 United Therapeutics shares in Q1 2016, an estimated $22.3K.
  • United Therapeutics made up 0.01% of Gupta Wealth Management's portfolio in Q1 2016, its #563 holding.
  • Gupta Wealth Management first reported a position in United Therapeutics in Q4 2015 and has held it in 2 quarters since.
  • 399 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2016.

Based on Gupta Wealth Management's 13F filing for Q1 2016, filed 16 May 2016.